Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

Clinical trial NCT02219711 · COMPLETED

Trial details

NCT number: NCT02219711
Sponsor: Mirati Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2014-08-01
Primary completion: 2022-04-27
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.